Community and individual approach to preventing diseases, improving quality of life and reducing social inequalities.
Professor Katharine Barnard-Kelly PhD, Practitioner Psychologist (HCPC Registration: PYL02075)
Leading clinical trials and other research to assess quality of life and patient-reported outcomes of therapies, devices and novel interventions
We employ rigorous and robust qualitative and quantitative methodologies
We provide high quality tailored research services and health psychology expertise
We lead psychosocial investigation in clinical trials to complement biomedical and safety outcomes
PATIENT REPORTED OUTCOMES
Development of patient-reported outcomes and patient preference measures
Expert advice on effective use of validated and reliable measures.
We ensure outcomes provide clarity of functionality, patient interaction with devices for optimal usage and better psychosocial functioning and quality of life.
KEY OPINION LEADERS
Research advisory boards
Industry advisory boards
Clinical research funding boards
New and higher regulatory standards have led to human factors and patient-reported outcome gaps in product submission
Provide high quality tailored human factors assessment and research services in evidence submissions, patient preference outcomes and patient engagement
Ensure assessments span age, gender, ethnicity, socio-economic status and health literacy using validated and reliable measures
Ensure outcomes provide clarity of functionality, patient interaction with devices for optimal usage and better psychosocial functioning and quality of life
AT THE HELM
Professor Katharine Barnard PhD, Chartered Health Psychologist, specializes in human factors assessment and the psychosocial impact of disease. She has a longstanding research interest in human factors, patient engagement and quality of life assessment. Her extensive evidence-based, theory-driven research portfolio has provided valuable insights into factors contributing to therapy choice, technology uptake and quality of life; behavioural interventions and the far-reaching impact of disability and disease on individuals and their family members.
Prof Barnard is currently leading on human factors assessment, patient preference, trade-offs and psychosocial assessment of diabetes technologies; she is an Expert Adviser to NICE; a close collaborator with the FDA and is the UK psychological lead on research to enhance patient engagement, optimised self-management heath behaviours, device functionality and human interaction thereof.
KALMOD Community Interest Company is the non-profit arm of Barnard Health Limited. The primary purpose is to serve the community of those who support individuals with disabilities and chronic conditions. Established to ring-fence profits from KALMOD Intervention tool to be used on good causes and reinvested into the community.
KALMOD THE TOOL
Copyright © 2017 Katharine Barnard all intellectual property rights reserved
KALMOD Behaviours For Health provides a novel, individually tailored health service to improve patient empowerment, quality of life and improved disease self-management.
The underpinning Kaleidoscope Model of Care is unique. It is a holistic, wide-reaching model that addresses all aspects of living with chronic conditions to improve outcomes.
Provides an easy-to-use package of care for each person and their healthcare professional designed to meet their individual needs, streamlining healthcare processes and challenging current boundaries and norms of operation.
Streamlines healthcare delivery in consultations, without extending consultation time.
Facilitates more focused, productive consultations for people with diabetes and healthcare professionals to ensure each are able to achieve their own targets.
Removes the pressure from healthcare professionals to provide ‘the’ answer without really understanding personal barriers to self-management.
Removes pressure to conform to treatment that may not fit with individuals’ preferences and circumstances.
Identifies person and treatment options/medical devices to be aligned for best long-term, sustainable usage
Is scalable, modifiable to other chronic health conditions, adaptable to different languages, easily updatable to meet new care pathways and at minimum cost.
Significantly improves the healthcare experience, improves outcomes and reduces the risks of long-term complications by engaging patients in a holistic assessment, with responsibility for self-management with the patient and responsibility for the process and delivery of best practice healthcare with healthcare professionals.